BioPlus Acquisition Corp.

CIK:0001856653|SEC Filings

Condensed Consolidated Statements Of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
General, administrative and operating costs	$ 1,278,991	$ 255,424	$ 1,554,265	$ 562,613
Loss from operations	(1,278,991)	(255,424)	(1,554,265)	(562,613)
Other income:
Interest earned on cash and investments held in Trust Account	2,519,539	280,345	5,116,177	325,712
Net income (loss)	$ 1,240,548	$ 24,921	$ 3,561,912	$ (236,901)
Class A Ordinary Shares [Member]
Other income:
Weighted average shares outstanding, Basic	20,500,762	23,560,000	22,021,930	23,560,000
Basic net income (loss) per share	$ 0.05	$ 0	$ 0.13	$ (0.01)
Weighted average shares outstanding, Diluted	20,500,762	23,560,000	22,021,930	23,560,000
Diluted net income (loss) per share	$ 0.05	$ 0	$ 0.13	$ (0.01)
Class B Ordinary Shares [Member]
Other income:
Weighted average shares outstanding, Basic	3,980,770	5,750,000	4,860,497	5,750,000
Basic net income (loss) per share	$ 0.05	$ 0	$ 0.13	$ (0.01)
Weighted average shares outstanding, Diluted	3,980,770	5,750,000	4,860,497	5,750,000
Diluted net income (loss) per share	$ 0.05	$ 0	$ 0.13	$ (0.01)

Condensed Consolidated Statements Of Cash Flows - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 1,240,548	$ 24,921	$ 3,561,912	$ (236,901)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on cash and investments held in Trust Account	(2,519,539)	(280,345)	(5,116,177)	(325,712)
Changes in operating assets and liabilities:
Prepaid expenses			214,075	159,369
Accrued expenses			145,664	129,895
Net cash used in operating activities			(1,194,526)	(273,349)
Cash Flows from Investing Activities:
Investment of cash into Trust Account			(250,000)	0
Cash withdrawn from Trust Account in connection with redemption			104,708,795	0
Net cash provided by investing activities			104,458,795	0
Cash Flows from Financing Activities:
Advances from related party			1,056,678	3,671
Proceeds from working capital loan			250,000	(3,671)
Redemption of common stock			(104,708,795)	(67,500)
Net cash used in financing activities			(103,402,117)	(67,500)
Net Change in Cash			(137,848)	(340,849)
Cash – Beginning of period			140,302	635,542
Cash – End of period	$ 2,454	$ 294,693	$ 2,454	$ 294,693

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 2,454	$ 140,302
Prepaid expenses	194,386	408,461
Total Current Assets	196,840	548,763
Cash and investments held in Trust Account	138,433,205	237,775,823
TOTAL ASSETS	138,630,045	238,324,586
Current liabilities
Accrued expenses	408,814	263,150
Working capital loan	250,000	0
Total Current Liabilities	1,979,217	526,875
Sponsor Loan	5,000,000	5,000,000
Deferred underwriting fee payable	9,800,000	9,800,000
TOTAL LIABILITIES	16,779,217	15,326,875
COMMITMENTS AND CONTINGENCIES
Class A ordinary shares subject to possible redemption; $0.0001 par value, 13,057,477 and 23,000,000 shares issued and outstanding at approximately $10.60 and $10.34 per share, redemption value as of June 30, 2023 and December 31, 2022, respectively	138,433,205	237,775,823
SHAREHOLDERS' DEFICIT
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional paid-in capital
Accumulated deficit	(16,583,008)	(14,778,743)
TOTAL SHAREHOLDERS' DEFICIT	(16,582,377)	(14,778,112)
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT	138,630,045	238,324,586
Related Party [Member]
Current liabilities
Advance from related parties	1,320,403	263,725
Common Class A
Current liabilities
Class A ordinary shares subject to possible redemption; $0.0001 par value, 13,057,477 and 23,000,000 shares issued and outstanding at approximately $10.60 and $10.34 per share, redemption value as of June 30, 2023 and December 31, 2022, respectively	138,433,205	237,775,823
SHAREHOLDERS' DEFICIT
Common stock value	631	56
Common Class B [Member]
SHAREHOLDERS' DEFICIT
Common stock value	$ 0	$ 575